Tyra Biosciences (TYRA) News
NASDAQ: TYRAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
20.12+0.39 (+1.98%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
TYRA news summary
We found 3 recent headlines mentioning Tyra Biosciences (TYRA): 0 in the past week and 3 in the past 30 days, most often from PR Newswire, Seeking Alpha. For price context, TYRA is up 1.98% at $20.12. The most recent story, "Tyra Biosciences GAAP EPS of -$0.74 misses by $0.07", was published by Seeking Alpha on Nov 10, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Tyra Biosciences headlines
- Tyra Biosciences GAAP EPS of -$0.74 misses by $0.07Seeking Alpha
- Tyra Biosciences Reports Third Quarter 2026 Financial Results and Recent HighlightsReported initial Phase 2 SURF302 results for oral dabogratinib in FGFR3-altered low-grade IR NMIBC patients Completed $400 million financing, providing additional capital to advance dabogratinib's…PR Newswire
- Tyra Biosciences to Participate in Upcoming Investor ConferencesCARLSBAD, Calif., Nov. 5, 2026 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target…PR Newswire